Salesforce (CRM) Stock Forecast & Price Target

$272.36 -2.15 (-0.78%)

Closing price 06/9/2025 03:59 PM Eastern

Extended Trading

$272.68 +0.32 (+0.12%)

As of 06/9/2025 07:59 PM Eastern

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 42 Analyst Ratings

Sell
2

Hold
9

Buy
31

Based on 42 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 42 analysts, 2 have given a sell rating, 9 have given a hold rating, 27 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$346.34
27.16% Upside

According to the 42 analysts' twelve-month price targets for Salesforce, the average price target is $346.34. The highest price target for CRM is $450.00, while the lowest price target for CRM is $200.00. The average price target represents a forecasted upside of 27.16% from the current price of $272.36.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

CRM Analyst Ratings Over Time

Type	Current Forecast 6/10/24 to 6/10/25	1 Month Ago 5/11/24 to 5/11/25	3 Months Ago 3/12/24 to 3/12/25	1 Year Ago 6/11/23 to 6/10/24
Strong Buy	4 Strong Buy rating(s)	5 Strong Buy rating(s)	4 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	27 Buy rating(s)	32 Buy rating(s)	30 Buy rating(s)	24 Buy rating(s)
Hold	9 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	9 Hold rating(s)
Sell	2 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$346.34	$350.56	$365.62	$292.79
Forecasted Upside	27.16% Upside	27.30% Upside	28.34% Upside	21.03% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.79	2.66	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	27.16% Upside	98.53% Upside	13.46% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/5/2025	Erste Group Bank 3 of 5 stars	H. Engel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
6/3/2025	Cantor Fitzgerald 3 of 5 stars	Matthew Vanvliet Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight ➝ Overweight	$325.00	+24.39%
5/30/2025	Citigroup 3 of 5 stars	T. Radke Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$320.00 ➝ $295.00	+11.92%
5/30/2025	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Huff Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$311.00 ➝ $309.00	+16.88%
5/29/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$393.00 ➝ $404.00	+46.87%
5/29/2025	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$380.00 ➝ $370.00	+34.51%
5/29/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$420.00 ➝ $275.00	-0.03%
5/29/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$255.00 ➝ $275.00	+4.94%
5/29/2025	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nehal Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$423.00 ➝ $396.00	+51.50%
5/29/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$425.00 ➝ $347.00	+34.38%
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
5/29/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$340.00 ➝ $385.00	+47.64%
5/29/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Moerdler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Underperform ➝ Underperform	$243.00 ➝ $255.00	-7.30%
5/28/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$315.00 ➝ $335.00	+21.53%
5/28/2025	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underperform ➝ Underperform	$200.00	-27.15%
5/28/2025	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$400.00 ➝ $350.00	+26.39%
5/28/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$400.00	+44.44%
5/28/2025	Westpark Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Shauger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$320.00	+15.55%
5/27/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$320.00 ➝ $300.00	+7.87%
5/27/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$367.00 ➝ $350.00	+28.18%
5/15/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$425.00 ➝ $380.00	+30.85%
4/21/2025	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Difucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral
3/31/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$425.00 ➝ $375.00	+43.23%
3/20/2025	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$320.00 ➝ $320.00	+14.67%
3/17/2025	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Sector Outperform ➝ Sector Outperform	$400.00 ➝ $345.00	+23.43%
2/27/2025	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$330.00 ➝ $300.00	+0.80%
2/27/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$425.00 ➝ $375.00	+24.79%
2/27/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$430.00 ➝ $400.00	+30.21%
2/27/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$440.00 ➝ $400.00	+30.21%
2/19/2025	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	O. Sheikh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
1/17/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Derrick Wood Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$380.00 ➝ $400.00	+24.62%
12/18/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$450.00 ➝ $450.00	+27.15%
12/18/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$425.00 ➝ $425.00	+21.08%
12/13/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ader Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Weight ➝ Overweight	$440.00	+22.84%
12/4/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$340.00 ➝ $380.00	+3.28%
12/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$380.00 ➝ $400.00	+20.57%
10/17/2024	Cfra	Aaron Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$343.00	+16.88%
10/2/2024	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seyrafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
Elon’s BIGGEST warning yet? (Ad) Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again.
8/29/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$335.00 ➝ $335.00	+28.58%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$325.00 ➝ $350.00	+35.19%
8/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+13.39%
5/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$350.00 ➝ $300.00	+39.82%
4/16/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$365.00	+33.82%
3/6/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$290.00 ➝ $354.00	+16.46%
9/15/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$267.00	+22.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:09 AM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, June 9, 2025. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

The current stock price is around $279, which reflects a strong market position and potential for growth.
Salesforce, Inc. has a relatively low payout ratio of 25.98%, indicating that the company retains a significant portion of its earnings for reinvestment, which can drive future growth.
Recent analyst ratings show a consensus of "Moderate Buy," with a majority of analysts recommending the stock, suggesting confidence in its future performance.
Salesforce, Inc. has received multiple price target upgrades from various research firms, indicating positive sentiment and expectations for stock appreciation.
The company is a leader in Customer Relationship Management technology, which is increasingly essential for businesses looking to enhance customer engagement and drive sales.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

Insider selling activity has been notable, with significant shares sold recently, which may raise concerns about the company's future prospects from those who are most familiar with its operations.
Some analysts have downgraded their price targets, indicating potential volatility and uncertainty in the stock's future performance.
The company faces increasing competition in the CRM space, which could impact its market share and profitability.
Salesforce, Inc. has a relatively modest dividend yield of 0.61%, which may not be attractive for income-focused investors.
Market conditions can be unpredictable, and any economic downturn could adversely affect Salesforce's growth trajectory and stock performance.

CRM Forecast - Frequently Asked Questions

: According to the research reports of 42 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $346.34, with a high forecast of $450.00 and a low forecast of $200.00.
: 42 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last twelve months. There are currently 2 sell ratings, 9 hold ratings, 27 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRM shares.
: According to analysts, Salesforce's stock has a predicted upside of 27.16% based on their 12-month stock forecasts.
: Over the previous 90 days, Salesforce's stock had 3 upgrades and 2 downgrades by analysts.
: Salesforce has been rated by research analysts at Barclays, BMO Capital Markets, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, DA Davidson, Erste Group Bank, Guggenheim, Jefferies Financial Group, Macquarie, Mizuho, Morgan Stanley, Needham & Company LLC, Northland Securities, Oppenheimer, Piper Sandler, Royal Bank of Canada, Sanford C. Bernstein, Scotiabank, Stephens, The Goldman Sachs Group, UBS Group, Wells Fargo & Company, and Westpark Capital in the past 90 days.
: Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.79 while the average consensus rating score for "computer and technology" companies is 2.66. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CRM) was last updated on 6/10/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target